Evogene Financial Results and Earnings Announcement Schedule for the Second Quarter of 2021
Evogene Ltd. (NASDAQ: EVGN) announces its second quarter financial results will be released on August 11, 2021. Incoming Chairperson of the Board, Ms. Sarit Firon, will discuss her vision during the conference call at 09:00 AM Eastern Time. The call can be accessed via phone or live webcast on the company's website. The replay will be available shortly after the call until August 13, 2021. Evogene focuses on life-science product development through its Computational Predictive Biology (CPB) platform, targeting sectors like human health and agriculture.
- None.
- None.
REHOVOT, Israel, July 28, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announces today that it will release its financial results for the second quarter of 2021 on Wednesday, August 11th, 2021. Ms. Sarit Firon Evogene's incoming Chairperson of the Board, will join the conference call to discuss her vision for Evogene.
On the day of the announcement, the Company's management will host a conference call to discuss the results at 09:00 AM Eastern time, 16:00 Israel time. To access the conference call, please dial +1-888-281-1167 toll free from the United States, or +972-3-918-0609 internationally. Access to the call will also be available via live webcast through the Company's website at www.evogene.com.
A replay of the conference call will be available approximately two hours following the completion of the call. To access the replay, please dial +1-888-326-9310 toll free from the United States, or +972-3-925-5901 internationally. The replay will be accessible through August 13th, 2021, and an archive of the webcast will be available on the webcast link for the following twelve months.
About Evogene Ltd.:
Evogene (NASDAQ: EVGN, TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of our broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Casterra Ltd. For more information, please visit www.evogene.com.
Evogene Investor Contact:
Aviva Banczewski / Rivka Neufeld
Investor Relations and Public Relations Manager
E: IR@evogene.com
T: +972-8-931-1900
US Investor Relations:
Joseph Green
Edison Group
E: jgreen@edisongroup.com
T: +1 646-653-7030
Laine Yonker
Edison Group
E: lyonker@edisongroup.com
T: +1 646-653-7035
View original content:https://www.prnewswire.com/news-releases/evogene-financial-results-and-earnings-announcement-schedule-for-the-second-quarter-of-2021-301343032.html
SOURCE Evogene
FAQ
When will Evogene release its Q2 2021 financial results?
Who will discuss Evogene's vision during the earnings call?
What time is the Evogene Q2 2021 earnings call scheduled?
How can I access the Evogene earnings call?
How long will the replay of Evogene's earnings call be available?
